KCTD17 and metabolic dysfunction-associated steatohepatitis: Elevated KCTD17 levels in the liver of patients with MASH were associated with increased fibrosis, while hepatocyte-specific depletion of Kctd17 in mice reduced both fibrosis and hepatocellular injury.